Hims & Hers Health, Inc. Class Action Lawsuit Filed, Lead Plaintiff Deadline is August 25, 2025

Strategic Insights -

The Rosen Law Firm, a global investor rights law firm, reminds investors of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) of the important lead plaintiff deadline for the class action lawsuit. The lawsuit alleges that the company made false and misleading statements about its partnership with Novo Nordisk A/S and its users' access to Wegovy, a weight-loss drug. Investors who purchased Hims common stock during the Class Period may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement.

Key Takeaways:

  • The Rosen Law Firm reminds investors of the lead plaintiff deadline for the Hims & Hers Health, Inc. class action lawsuit, which is August 25, 2025.
  • The lawsuit alleges that Hims made false and misleading statements about its partnership with Novo Nordisk A/S and its users' access to Wegovy, a weight-loss drug.
  • Investors who purchased Hims common stock between April 29, 2025 and June 23, 2025 may be entitled to compensation through a contingency fee arrangement.
  • The Rosen Law Firm has a record of success in securities class actions and shareholder derivative litigation, and its attorneys have been recognized by Lawdragon and Super Lawyers.
  • The firm has secured hundreds of millions of dollars for investors, including $438 million in 2019 and $438 million in 2020.
  • The lawsuit claims that investors suffered damages when the true details of the Novo partnership and Hims users' access to Wegovy entered the market.
  • To join the Hims class action, investors can go to https://rosenlegal.com/submit-form/?case_id=40578 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information.

Statistics:

  • $438 million: The amount of money secured by the Rosen Law Firm for investors in 2019.
  • $438 million: The amount of money secured by the Rosen Law Firm for investors in 2020.
  • August 25, 2025: The lead plaintiff deadline for the Hims & Hers Health, Inc. class action lawsuit.
  • April 29, 2025 to June 23, 2025: The class period during which investors who purchased Hims common stock may be entitled to compensation.
  • $0: The amount of out-of-pocket fees or costs that investors may need to pay to join the Hims class action lawsuit, thanks to the contingency fee arrangement.

Sources:

  • https://www.newsfilecorp.com/release/259475
  • https://rosenlegal.com/
  • Lawdragon
  • Super Lawyers